Molecular Neurogenetics Unit, Center for Human Genetic Research, Department of Neurology, Massachusetts General Hospital, Boston, MA 02114, USA.
J Biomed Sci. 2012 Apr 10;19(1):41. doi: 10.1186/1423-0127-19-41.
Many neurodegenerative disorders, although related by their destruction of brain function, display remarkable cellular and/or regional pathogenic specificity likely due to a deregulated functionality of the mutant protein. However, neurodegenerative disease genes, for example huntingtin (HTT), the ataxins, the presenilins (PSEN1/PSEN2) are not simply localized to neurons but are ubiquitously expressed throughout peripheral tissues; it is therefore paramount to properly understand the earliest precipitating events leading to neuronal pathogenesis to develop effective long-term therapies. This means, in no unequivocal terms, it is crucial to understand the gene's normal function. Unfortunately, many genes are often essential for embryogenesis which precludes their study in whole organisms. This is true for HTT, the β-amyloid precursor protein (APP) and presenilins, responsible for early onset Alzheimer's disease (AD). To better understand neurological disease in humans, many lower and higher eukaryotic models have been established. So the question arises: how reasonable is the use of organisms to study neurological disorders when the model of choice does not contain neurons? Here we will review the surprising, and novel emerging use of the model organism Dictyostelium discoideum, a species of soil-living amoeba, as a valuable biomedical tool to study the normal function of neurodegenerative genes. Historically, the evidence on the usefulness of simple organisms to understand the etiology of cellular pathology cannot be denied. But using an organism without a central nervous system to understand diseases of the brain? We will first introduce the life cycle of Dictyostelium, the presence of many disease genes in the genome and how it has provided unique opportunities to identify mechanisms of disease involving actin pathologies, mitochondrial disease, human lysosomal and trafficking disorders and host-pathogen interactions. Secondly, I will highlight recent studies on the function of HTT, presenilin γ-secretase and Hirano bodies conducted in Dictyostelium. I will then outline the limitations and future directions in using Dictyostelium to study disease, and finally conclude that given the evolutionary conservation of genes between Dictyostelium and humans and the organisms' genetic tractability, that this system provides a fertile environment for discovering normal gene function related to neurodegeneration and will permit translational studies in higher systems.
许多神经退行性疾病虽然都与脑功能的破坏有关,但表现出显著的细胞和/或区域致病性特异性,这可能是由于突变蛋白的功能失调。然而,神经退行性疾病基因,例如亨廷顿蛋白(HTT)、ataxins、早老素(PSEN1/PSEN2),并不仅仅局限于神经元,而是在周围组织中广泛表达;因此,正确理解导致神经元发病的早期引发事件对于开发有效的长期治疗方法至关重要。这意味着,毫不含糊地说,了解基因的正常功能至关重要。不幸的是,许多基因对于胚胎发生通常是必需的,这使得它们无法在整个生物体中进行研究。这对于 HTT、β-淀粉样前体蛋白(APP)和早老素都是如此,它们负责早发性阿尔茨海默病(AD)。为了更好地理解人类的神经疾病,已经建立了许多较低和较高等的真核生物模型。那么问题来了:当所选模型不包含神经元时,使用生物体来研究神经疾病的合理性如何?在这里,我们将回顾令人惊讶的、新颖的土壤阿米巴物种——盘基网柄菌(Dictyostelium discoideum)模型的新兴用途,作为研究神经退行性基因正常功能的有价值的生物医学工具。从历史上看,简单生物体对于理解细胞病理学病因的有用性的证据是不可否认的。但是,使用没有中枢神经系统的生物体来理解大脑疾病?我们将首先介绍盘基网柄菌的生命周期、基因组中存在的许多疾病基因,以及它如何为鉴定涉及肌动蛋白病理学、线粒体疾病、人类溶酶体和运输障碍以及宿主-病原体相互作用的疾病机制提供独特的机会。其次,我将重点介绍最近在盘基网柄菌中进行的 HTT、早老素 γ-分泌酶和 Hirano 体的功能研究。然后,我将概述使用盘基网柄菌研究疾病的局限性和未来方向,最后得出结论,鉴于 Dictyostelium 和人类之间基因的进化保守性以及生物体的遗传可操作性,该系统为发现与神经退行性变相关的正常基因功能提供了肥沃的环境,并将允许在更高的系统中进行转化研究。